These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1134882)

  • 1. Pulmonary hypersensitivity associated with pancreatin powder exposure.
    Bergner A; Bergner RK
    Pediatrics; 1975 Jun; 55(6):814-7. PubMed ID: 1134882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchial asthma due to allergy to pancreatic extract: a hazard in the treatment of cystic fibrosis.
    Sakula A
    Br J Dis Chest; 1977 Oct; 71(4):295-9. PubMed ID: 588432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein breath test: evidence for normalized fat assimilation with high dose pancreatin therapy.
    Braden B; Picard H; Caspary WF; Posselt HG; Lembcke B
    Z Gastroenterol; 1997 Feb; 35(2):123-9. PubMed ID: 9066102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrosing colonopathy in children with cystic fibrosis.
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S11-29. PubMed ID: 8869179
    [No Abstract]   [Full Text] [Related]  

  • 6. Direct assessment of gastrointestinal inflammation and mucosal immunity in children with cystic fibrosis.
    Croft NM; Marshall TG; Ferguson A
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S32-6. PubMed ID: 8869180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel tobramycin inhalation powder in cystic fibrosis subjects: pharmacokinetics and safety.
    Geller DE; Konstan MW; Smith J; Noonberg SB; Conrad C
    Pediatr Pulmonol; 2007 Apr; 42(4):307-13. PubMed ID: 17352404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic clinical trial sedative Edym (capsules). Results obtained in 50 patients].
    Bordas Alsina DJ
    Rev Esp Enferm Apar Dig; 1973 Nov; 41(5):629-36. PubMed ID: 4770561
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of fenoterol powder capsules and fenoterol metered dose spray in bronchial asthma.
    Boye NP; Kornstad S
    Eur J Respir Dis Suppl; 1983; 130():9-11. PubMed ID: 6581065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fatty acids composition of serum lipid fractions in children with cystic fibrosis of the pancreas before and after treatment with pancreatin].
    Annibaldi L; Antonelli M; Ballati G; Giardini O; Cardi E
    Riv Clin Pediatr; 1968; 81(5):962-4. PubMed ID: 5740224
    [No Abstract]   [Full Text] [Related]  

  • 11. Porcine pancreatin as a source of salmonella infection in children with cystic fibrosis.
    Lipson A; Meikle H
    Arch Dis Child; 1977 Jul; 52(7):569-72. PubMed ID: 879849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multicenter comparative study of a new formulation of pancreatin in gastro-resistant microgranules for the treatment of exocrine pancreatic insufficiency in children with mucoviscidosis].
    Duhamel JF; Vidailhet M; Le Luyer B; Douchain F; Jehanne M; Clavel R; Guillot M
    Ann Pediatr (Paris); 1988 Jan; 35(1):69-74. PubMed ID: 3284429
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative study of the effect of kreon and cotazyme forte in children with cystic fibrosis].
    Zsíros J; Sólyom E
    Orv Hetil; 1988 May; 129(19):995-9. PubMed ID: 3290773
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages.
    Ansaldi-Balocco N; Santini B; Sarchi C
    J Pediatr Gastroenterol Nutr; 1988; 7 Suppl 1():S40-5. PubMed ID: 3042938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quantitative variations of serum lipid fractions in 10 children with cystic fibrosis before and after the pancreatin therapy].
    Antonelli M; Giardini O; Ballati G; Cardi E
    Riv Clin Pediatr; 1968; 81(5):949-51. PubMed ID: 5740221
    [No Abstract]   [Full Text] [Related]  

  • 16. First adult patient with fibrosing colonopathy.
    Häusler M; Meilicke R; Biesterfeld S; Heimann G
    Am J Gastroenterol; 1998 Jul; 93(7):1171-2. PubMed ID: 9672356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the United States epidemiology study.
    Littlewood JM
    Postgrad Med J; 1996 Mar; 72 Suppl 2():S6; discussion S7-10. PubMed ID: 8869178
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of pancreatic enzyme microsphere technology and US findings with Pancrease in the treatment of chronic pancreatitis.
    DeYoung JL
    Int J Pancreatol; 1989; 5 Suppl():31-6. PubMed ID: 2702248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical trial of several preparation types of the pancreatic extract Pancrex V in the treatment of cystic fibrosis].
    Braggion C; Mastella G
    Minerva Pediatr; 1985 Nov; 37(21-22):891-6. PubMed ID: 3912659
    [No Abstract]   [Full Text] [Related]  

  • 20. Pancreatic enzyme pharmacotherapy.
    Ferrone M; Raimondo M; Scolapio JS
    Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.